GlycA, a Nuclear Magnetic Resonance Spectroscopy Measure for Protein Glycosylation, is a Viable Biomarker for Disease Activity in IBD

BACKGROUND AND AIMS: Glycoprotein acetylation [GlycA] is a novel nuclear magnetic resonance [NMR] biomarker, measured in serum or plasma, that summarizes the signals originating from glycan groups of certain acute-phase glycoproteins. This biomarker has been shown to be robustly associated with card...

Descripción completa

Detalles Bibliográficos
Autores principales: Dierckx, Tim, Verstockt, Bram, Vermeire, Séverine, van Weyenbergh, Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Short Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434738/
https://www.ncbi.nlm.nih.gov/pubmed/30312386
http://dx.doi.org/10.1093/ecco-jcc/jjy162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434738/
https://www.ncbi.nlm.nih.gov/pubmed/30312386
http://dx.doi.org/10.1093/ecco-jcc/jjy162

Ejemplares similares